{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T19:20:32Z","timestamp":1773170432458,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.dld.2013.12.014","type":"journal-article","created":{"date-parts":[[2014,1,26]],"date-time":"2014-01-26T09:46:00Z","timestamp":1390729560000},"page":"465-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Five cases of sprue-like enteropathy in patients treated by olmesartan"],"prefix":"10.1016","volume":"46","author":[{"given":"H\u00e9l\u00e8ne","family":"Th\u00e9ophile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier-Richard","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada","family":"Miremont-Salam\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Haramburu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2013.12.014_bib0005","series-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","year":"2004"},{"key":"10.1016\/j.dld.2013.12.014_bib0010","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2013.12.014_bib0015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.mayocp.2012.06.003","article-title":"Severe spruelike enteropathy associated with olmesartan","volume":"87","author":"Rubio-Tapia","year":"2012","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.dld.2013.12.014_bib0020","doi-asserted-by":"crossref","first-page":"618071","DOI":"10.1155\/2013\/618071","article-title":"Spruelike enteropathy associated with olmesartan: an unusual case of severe diarrhea","volume":"2013","author":"Dreifuss","year":"2013","journal-title":"Case Reports in Gastrointestinal Medicine"},{"key":"10.1016\/j.dld.2013.12.014_bib0025","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/MCG.0b013e31829a27e6","article-title":"Olmesartan-associated sprue-like enteropathy","volume":"47","author":"Stanich","year":"2013","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2013.12.014_bib0030","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1053\/j.gastro.2006.10.004","article-title":"American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease","volume":"131","author":"Rostom","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.12.014_bib0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ajg.2013.45","article-title":"Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma","volume":"108","author":"DeGaetani","year":"2013","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.12.014_bib0040","series-title":"Potential Signals of Serious Risks\/New Safety Information Identified by the Adverse Event Reporting System (AERS) between April\u2013June 2012. Information posted on line by the FDA on October 18, 2012","author":"FDA","year":"2013"},{"key":"10.1016\/j.dld.2013.12.014_bib0045","series-title":"FDA Drug Safety Communication: FDA approves label changes to include intestinal problems (sprue-like enteropathy) linked to blood pressure medicine olmesartan medoxomil","author":"FDA","year":"2013"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865813007020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865813007020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T02:52:12Z","timestamp":1538880732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865813007020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1590865813007020"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2013.12.014","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Five cases of sprue-like enteropathy in patients treated by olmesartan","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2013.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}